Related Experiment Video
Updated: Jun 18, 2026
09:01
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.2K
Self-Propelled Magnetic Nanorobots Alleviating Tumor Hypoxia for Targeted Drug Delivery
Shikang Liu1, Yijie Lu1, Qiaoli Feng2
1Spin-X Institute, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, 511442, China.
Small (Weinheim an Der Bergstrasse, Germany)
|August 18, 2025
Summary
Researchers developed magnetic nanorobots that can penetrate tumors and improve the hypoxic microenvironment. These nanorobots deliver drugs effectively for enhanced tumor treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Tumor biological barriers and hypoxia impede effective clinical treatments.
- Self-propelled nanorobots offer a solution for deep drug penetration and hypoxia amelioration.
Purpose of the Study:
- To develop a magnetic nanorobot platform for enhanced tumor drug delivery and treatment.
- To address challenges posed by tumor biological barriers and hypoxic microenvironments.
Main Methods:
- Designed asymmetric badminton-shaped magnetic nanorobots with a microporous tail.
- Functionalized nanorobots with lactate dehydrogenase, catalase, and triptolide.
- Enhanced active targeting using nucleic acid aptamer surface modification.
Main Results:
- Enzymatic cascade reaction propelled nanorobots and improved tumor hypoxia by degrading lactic acid.
- Demonstrated deep drug delivery capabilities through in vitro simulations.
- Validated significant tumor treatment efficacy in biological experiments.
Conclusions:
- The developed magnetic nanorobots show promise for overcoming biological barriers and hypoxic conditions in tumors.
- This platform offers a novel strategy for advanced deep tumor treatment applications.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...